创新药物MDM2-p53拮抗剂治疗DDLPS临床试验中国入组首例患者
Ebiotrade,
编辑推荐： 上海2023年1月6日 /美通社/ -- 2023年1月5日，勃林格殷格翰宣布，其在研创新药物MDM2-p53拮抗剂BI 907828用于一线治疗去分化脂肪肉瘤（DDLPS）Ⅱ/Ⅲ期临床试验Brig...
Emerging Role for Precision Therapy Through Next-Generation Sequencing for Sarcomas
Overview of attention for article published in JCO Precision Oncology, November 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (74th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 8 Mendeley